Calcium rosuvastatin

Apejuwe kukuru:

Orukọ API Itọkasi Sipesifikesonu US DMF EU DMF CEP
Calcium rosuvastatin Hypercholesterolemia Ninu Ile / CEP Ọdun 20705 CEP2015-240


Alaye ọja

ọja Tags

Apejuwe ọja

瑞舒伐他汀钙 Calcium rosuvastatin 147098-20-2 Ninu Ile / CEP
RSM(Kristali) 147118-40-9 Ninu Ile
RSM(Robi) 147118-40-9 Ninu Ile
RSP - Ninu Ile
RS-8 147118-36-3 Ninu Ile
RS-8-1 147118-37-4 Ninu Ile
TP-8 131466-61-0 Ninu Ile
TP-11 147118-35-2 Ninu Ile
TP-13 147118-39-6 Ninu Ile
RS-10 289042-12-2 Ninu Ile
RS-11 355806-00-7 Ninu Ile

Apejuwe

Calcium Rosuvastatin (BANM, JAN, USAN) ni a mọ ni Rosuvastatin ni AMẸRIKA.ati ifigagbaga HMG-CoA reductase inhibitor pẹlu IC50 ti 11 nM[1].Calcium Rosuvastatin ni agbara ti o ṣe idiwọ jiini ti o ni ibatan ether-a-go-go eniyan (hERG) lọwọlọwọ pẹlu IC50 ti 195 nM, idaduro isọdọtun ọkan ọkan, ati nitorinaa awọn akoko agbara ṣiṣe gigun (APDs) ati atunse aarin aarin QTc (QTc) [2].Calcium Rosuvastatin dinku ikosile ti hERG ti o dagba ati ibaraenisepo ti amuaradagba mọnamọna ooru 70 (Hsp70) pẹlu amuaradagba hERG.Calcium Rosuvastatin munadoko pupọ ni idinku lipoprotein iwuwo kekere (LDL) idaabobo awọ, triglycerides, ati awọn ipele amuaradagba C-reactive[3].

Alaye siwaju sii lori awọn apejọ isorukọsilẹ oogun: Awọn Orukọ Alailowaya Kariaye.

Akiyesi Pataki: Data data ilu okeere Drugs.com wa ninu itusilẹ BETA.Eyi tumọ si pe o tun wa labẹ idagbasoke ati pe o le ni awọn aiṣedeede ninu.Ko ṣe ipinnu bi aropo fun oye ati idajọ ti dokita rẹ, oloogun tabi alamọdaju ilera miiran.Ko yẹ ki o tumọ lati fihan pe lilo oogun eyikeyi ni orilẹ-ede eyikeyi jẹ ailewu, yẹ tabi munadoko fun ọ.Kan si alagbawo pẹlu alamọdaju ilera rẹ ṣaaju ki o to mu oogun eyikeyi.

Ni AMẸRIKA, Rosuvastatin (systemic rosuvastatin) jẹ ọmọ ẹgbẹ ti oogun oogun statins ati pe a lo lati ṣe itọju Atherosclerosis, Cholesterol giga, Cholesterol giga - Heterozygous idile, Cholesterol giga - Homozygous idile, Hyperlipoproteinemia, Hyperlipoproteinemia Iru IIa - Ilọsiwaju LDL, Iru LDL, Hyperlipoproteinemia. IIb - LDL VLDL ti o ga, Hyperlipoproteinemia Iru III - Beta-VLDL IDL ti o ga, Hyperlipoproteinemia Iru IV - VLDL ti o ga, Hypertriglyceridemia ati Idena Arun Arun inu ọkan.

abẹlẹ

Ayanfẹ, oludaniloju ifigagbaga ti HMG-CoA reductase, iyẹn tun jẹ antilipemic.

 

Ibi ipamọ

Lulú

-20°C

3 odun

4°C

ọdun meji 2
Ni epo

-80°C

osu 6

-20°C

osu 1

Ilana kemikali

Rosuvastatin Calcium

Ijẹrisi

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

Ìṣàkóso didara

Quality management1

Igbero18Awọn iṣẹ akanṣe Igbelewọn Iṣeduro Didara eyiti o ti fọwọsi4, ati6ise agbese ni o wa labẹ alakosile.

Quality management2

Eto iṣakoso didara agbaye ti ilọsiwaju ti fi ipilẹ to lagbara fun tita.

Quality management3

Abojuto didara n ṣiṣẹ nipasẹ gbogbo igbesi aye ọja lati rii daju didara ati ipa itọju ailera.

Quality management4

Ẹgbẹ Aṣoju Iṣeduro Ọjọgbọn ṣe atilẹyin awọn ibeere didara lakoko ohun elo ati iforukọsilẹ.

gbóògì isakoso

cpf5
cpf6

Koria Countec Bottled Packaging Line

cpf7
cpf8

Taiwan CVC Laini Iṣakojọpọ Igo

cpf9
cpf10

Italy CAM Board Packaging Line

cpf11

German Fette Compacting Machine

cpf12

Japan Viswill Tablet Oluwari

cpf14-1

DCS Iṣakoso yara

ALÁGBẸ́NI

International ifowosowopo
International cooperation
Abele ifowosowopo
Domestic cooperation

  • Ti tẹlẹ:
  • Itele:

  • Kọ ifiranṣẹ rẹ nibi ki o si fi si wa

    Awọn ẹka ọja